Related cases:
- TJD-AD 2021-017 Appeal Decision - Football
June 30, 2021 - TJD-AD 2021-018 Disciplinary Decision - Football
September 23, 2021 - TJD-AD 2021-027 Appeal Decision - Football
November 12, 2021
In June 2020 the Brazilian Doping Control Authority (ABCD) has reported an anti-doping rule violation against the football player after his A and B samples tested positive for the prohibited substance Dexamethasone. After notification a provisional suspension was ordered and the case was referred to the Brazilian Sports Justice Anti-Doping Tribunal (TJD-AD).
The Athlete denied the intentional use of the substance and argued that he acted with No Significant Fault or Negligence. He stated that he and two other football players had received Citoneurin and Miofibrax injections administered by the football club's physiotherapist as recommended by a doctor.
In view of the evidence in this case the Panel was troubled whether ABCD had established with sufficient evidence that the Athlete had acted intentionally, rather it had established that the football club's Athlete Support Personell were responsible for the violation.
Furthermore it remained unclear for the Panel whether the physiotherapist by mistake the medication Dexa Cetoneurim had administered instead of the Citoneurin and Miofibrax medication. Finally the Panel considers that there had been delays in the proceedings not attributed to the Athlete.
Therefore the TJD-AD Panel decides by majority on 22 April 2021 to impose a 2 month period of ineligibility on the Athlete, starting on the date of the sample collection, i.e. 12 August 2019. The Athlete already had served this sanction.
